drugset / Trial / NCT00919893
Efficacy Study of a Standardized Pollen Extract Preparation (Cernilton) to Treat Inflammatory Chronic Prostatitis-Chronic Pelvic Pain Syndrome (CP-CPPS)
Phase 3
Completed
139 enrolled
University of Giessen
Cernelle, Ängelholm, Sweden · collabStrathmann AG&Co, Hamburg, Germany · collab
RandomizedCrossoverDouble-blindTreatment
Summary
In this placebo controlled study the safety and efficacy of Cernilton, a standardized pollen extract, in men with inflammatory chronic prostatitis-chronic pelvic pain syndrome was investigated. The purpose of this study is to determine whether Cernilton is safe and effective in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome.
Timeline
- Start
- 1999-12
- Primary completion
- 2004-01
- Completion
- 2004-01
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cernilton | Traditional medicine (herbal / TCM) | — | Oral |